Timpani Capital Management’s OptimizeRx OPRX Stock Holding History

Timpani Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.34M	Sell	105,057 -3,586	-3%	-$46.6K	0.64%	60
2018 Q4	$1.19M	Buy	108,643 +36,949	+52%	+$547K	0.67%	59
2018 Q3	$1.29M	Buy	+71,694	New	+$903K	0.37%	81

Other funds holding OPRX

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return

Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return

1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Timpani Capital Management's OPRX Position: Q1 2019 in Review

Timpani Capital Management reduced its OptimizeRx (OPRX) stake by 3.3% in Q1 2019, selling an estimated $46.6K and leaving 105,057 shares worth $1.34M. The position accounts for 0.64% of the portfolio, ranked #60.

Timpani Capital Management first reported a position in OPRX in Q3 2018 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold OPRX as of Q1 2019.

Timpani Capital Management held 105,057 shares of OptimizeRx worth $1.34M as of Q1 2019.
Timpani Capital Management sold 3,586 OptimizeRx shares in Q1 2019, an estimated $46.6K.
OptimizeRx made up 0.64% of Timpani Capital Management's portfolio in Q1 2019, its #60 holding.
Timpani Capital Management first reported a position in OptimizeRx in Q3 2018 and has held it in 3 quarters since.
40 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.